Cobalt(II) ion (Co2+) (Co2+)

Cobalt(II) ion (Co2+) is a divalent metal cation that is essential to human health as the central component of Vitamin B12 (cobalamin), where it facilitates DNA synthesis and red blood cell maturation (NIH, 2024). Beyond its role as a nutrient, cobalt has been used pharmacologically to treat anemia due to its ability to stimulate the production of erythropoietin (MDPI, 2024). This effect occurs because cobalt ions inhibit prolyl hydroxylase enzymes, which leads to the stabilization of hypoxia-inducible factor 1-alpha (HIF-1α), effectively mimicking a state of cellular hypoxia (Cobalt Institute, 2022). However, the therapeutic use of cobalt is severely limited by its narrow safety margin and potential for multi-organ toxicity (ResearchGate, 2019). Chronic exposure or high doses can lead to beer drinker's cardiomyopathy, polycythemia, and thyroid enlargement (goiter) (Cobalt Institute, 2022). In modern medicine, cobalt is primarily encountered as a toxicant, making it a target for chelation therapy using agents like EDTA or penicillamine to prevent systemic damage (BioRxiv, 2020). Additionally, cobalt complexes are being investigated for potential antimicrobial and anticancer properties due to their ability to induce oxidative stress in target cells (NIH, 2022).

Other names

Cobaltous ionCo(II)Cobalt(2+)Divalent cobalt

Chelating agents target the cobalt(II) ion by forming stable, water-soluble coordination complexes that facilitate its renal clearance; when cobalt itself is used as a therapeutic agent, it acts by inhibiting prolyl hydroxylase domain (PHD) enzymes, which prevents the degradation of hypoxia-inducible factor 1-alpha (HIF-1α) and subsequently increases erythropoietin expression.